US Stocks
/
Xenetic Biosciences, Inc. Share Price
Xenetic Biosciences, Inc. Share Price

Xenetic Biosciences, Inc. Share Price

NASDAQ: XBIO | Micro Cap
$2.16
-$0.03 (-1.59%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Xenetic Biosciences, Inc. Stock Performance

Open
$2.16
Prev. Close
$2.19
Circuit Range
N/A
Day Range
$2.16 - $2.16
Year Range
$1.92 - $13.87
Volume
114
Average Traded
$2.16

Xenetic Biosciences, Inc. Share Price Today

As of 9 October 2026, Xenetic Biosciences, Inc.'s share price is $2.16. The stock opened at $2.16, compared to its previous close of $2.19. During today's trading session, Xenetic Biosciences, Inc.'s share price traded between $2.16 and $2.16, with an average price of $2.16. Over the past 52 weeks, the stock has recorded a high of $13.87 and a low of $1.92. In terms of performance, Xenetic Biosciences, Inc.'s share price has declined by 30.10% over the last six months and is down 35.04% on a year-on-year basis.

Xenetic Biosciences, Inc. Share Price Chart

$2.16$2.16
L
Show Current Price
H

Xenetic Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.68M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.06
Revenue (TTM)
$0.00
Return On Equity (TTM)
-40.76%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-82.35%

Xenetic Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.81$0.66
Net Profit-$0.51-$0.58-$0.46-$0.93
Net Profit MarginN/AN/A-56.79%-140.91%
Income ChangeN/A-13.73%20.69%-102.17%

Xenetic Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$2.54$0.00$0.00
Net Profit-$6.55-$4.13-$3.96-$2.68
Net Profit MarginN/A-162.60%N/AN/A
Income ChangeN/A36.95%4.12%32.32%

About Xenetic Biosciences, Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

Xenetic Biosciences, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.25
$2.16
-3.14%
Sep 2026
$4.43
$2.23
-42.00%
Aug 2026
$2.75
$3.85
+45.64%
Jul 2026
$2.85
$2.64
-12.29%
Jun 2026
$3.14
$3.01
-3.83%
May 2026
$3.15
$3.13
+1.29%
Apr 2026
$2.98
$3.09
+13.19%
Mar 2026
$2.52
$2.73
+13.75%
Feb 2026
$2.25
$2.40
+5.73%
Jan 2026
$2.15
$2.27
+6.57%
Dec 2025
$2.50
$2.13
-21.11%
Nov 2025
$3.17
$2.70
-18.80%

XBIO Share Price FAQs

What is Xenetic Biosciences, Inc. share price today?

chevron-up
Xenetic Biosciences, Inc. share price today is $2.16 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Xenetic Biosciences, Inc. stock?

chevron-up
The 52 week high of Xenetic Biosciences, Inc. stock is $13.87, while the 52 week low is $1.92 as of 9 Oct '26.

What is XBIO's market capitalisation today?

chevron-up
XBIO market capitalisation is $3.68M as of October 9, 2026, at 6:23 am IST.

What is XBIO's net income for the last quarter?

chevron-up
XBIO's net income for the last quarter is -0.93B USD.

What is the 5 year returns of XBIO?

chevron-up
The 5 year returns of XBIO is -87.07% as on 9 Oct '26.

What is the high & low stock price of XBIO today?

chevron-up
XBIO stock price hit a high of $2.16 and low of $2.16 as of 9 Oct '26.

Can I buy XBIO shares in India?

chevron-up
Yes. You can buy XBIO in India by opening an international trading account.